Literature DB >> 17327467

BetaIg-h3 is involved in the HAb18G/CD147-mediated metastasis process in human hepatoma cells.

Juan Tang1, Hong-wei Zhou, Jian-li Jiang, Xiang-min Yang, Yu Li, Hong-xin Zhang, Zhi-nan Chen, Wei-ping Guo.   

Abstract

HAb18G/CD147, a new hepatoma-associated antigen cloned and screened from human hepatocellular carcinoma cDNA library, is closely correlated with metastasis process in human hepatoma cells. In the present study we aimed to identify the pivotal molecules of the HAb18G/CD147 signal transduction pathway. The investigation showed that betaig-h3, a secretory extracellular matrix (ECM) protein, was upregulated in HAb18G/CD147-expressing human hepatoma T7721 cells and was downregulated by depressing HAb18G/CD147 expression. The expression of betaig-h3, upregulated in human hepatoma cells, was positively relative to the expression of HAb18G/CD147 in different human hepatoma cell lines. By overexpressing betaig-h3 in human SMMC-7721 hepatoma cells, we discovered that betaig-h3 promoted cell adhesion, invasion, and matrix metalloproteinase (MMP) secretion potential. HAb18G/CD147-induced invasion and metastasis potential of human hepatoma cells can be attenuated by antibodies specific for betaig-h3, and no significant differences on inhibitory effects were observed among T7721 cells incubated with antibodies for betaig-h3 or HAb18G/CD147 or both types together. Taken together, our study suggests that betaig-h3, regulated by the expression of HAb18G/CD147, is involved in the HAb18G/CD147 signal transduction pathway and mediates the HAb18G/CD147-induced invasion and metastasis process of human hepatoma cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17327467

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  17 in total

1.  Clinical impact of HAb18G/CD147 expression in esophageal squamous cell carcinoma.

Authors:  Shaojun Zhu; Yanhong Li; Li Mi; Yang Zhang; Li Zhang; Li Gong; Xiujuan Han; Li Yao; Miao Lan; Zhinan Chen; Wei Zhang
Journal:  Dig Dis Sci       Date:  2011-07-26       Impact factor: 3.199

2.  Increased expression of CD147 and MMP-9 is correlated with poor prognosis of salivary duct carcinoma.

Authors:  Songlin Piao; Shu Zhao; Fulin Guo; Jie Xue; Guodong Yao; Zhili Wei; Qi Huang; Yao Sun; Bin Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2012-01-04       Impact factor: 4.553

3.  Release of TGFβig-h3 by gastric myofibroblasts slows tumor growth and is decreased with cancer progression.

Authors:  Chris Holmberg; Michael Quante; Islay Steele; Jothi Dinesh Kumar; Silviya Balabanova; Cedric Duval; Matyas Czepan; Zoltan Rakonczay; Laszlo Tiszlavicz; Istvan Nemeth; Gyorgy Lazar; Zsolt Simonka; Rosalind Jenkins; Peter Hegyi; Timothy C Wang; Graham J Dockray; Andrea Varro
Journal:  Carcinogenesis       Date:  2012-05-18       Impact factor: 4.944

4.  CD147, MMP9 expression and clinical significance of basal-like breast cancer.

Authors:  Ying Liu; Tao Xin; Qiu-Ying Jiang; Da-Yong Huang; Wei-Xi Shen; Li Li; Yan-Ju Lv; Ying-Hua Jin; Xiao-Wei Song; Chong Teng
Journal:  Med Oncol       Date:  2013-01-06       Impact factor: 3.064

Review 5.  Cyclophilin-CD147 interactions: a new target for anti-inflammatory therapeutics.

Authors:  V Yurchenko; S Constant; E Eisenmesser; M Bukrinsky
Journal:  Clin Exp Immunol       Date:  2010-03-16       Impact factor: 4.330

6.  HAb18G/CD147 cell-cell contacts confer resistance of a HEK293 subpopulation to anoikis in an E-cadherin-dependent manner.

Authors:  Xiao-Kui Ma; Li Wang; Yu Li; Xiang-Ming Yang; Pu Zhao; Ping Zhu; Ling Li; Zhi-Nan Chen
Journal:  BMC Cell Biol       Date:  2010-04-17       Impact factor: 4.241

7.  Two novel VHL targets, TGFBI (BIGH3) and its transactivator KLF10, are up-regulated in renal clear cell carcinoma and other tumors.

Authors:  Sergey V Ivanov; Alla V Ivanova; Konstantin Salnikow; Olga Timofeeva; Malayannan Subramaniam; Michael I Lerman
Journal:  Biochem Biophys Res Commun       Date:  2008-03-24       Impact factor: 3.575

8.  High expression of CD147 and MMP-9 is correlated with poor prognosis of triple-negative breast cancer (TNBC) patients.

Authors:  Shu Zhao; Wenjie Ma; Minghui Zhang; Dabei Tang; Qingtao Shi; Shanqi Xu; Xiaosan Zhang; Yupeng Liu; Ying Song; Leyuan Liu; Qingyuan Zhang
Journal:  Med Oncol       Date:  2012-12-22       Impact factor: 3.064

9.  In silico analysis of combinatorial microRNA activity reveals target genes and pathways associated with breast cancer metastasis.

Authors:  Alan A Dombkowski; Zakia Sultana; Douglas B Craig; Hasan Jamil
Journal:  Cancer Inform       Date:  2011-02-17

Review 10.  Transforming growth Factor-Beta-Induced Protein (TGFBI)/(βig-H3): a matrix protein with dual functions in ovarian cancer.

Authors:  Miranda P Ween; Martin K Oehler; Carmela Ricciardelli
Journal:  Int J Mol Sci       Date:  2012-08-21       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.